Argint joins with Brookwood to offer clinical training in CEE

By Nick Taylor

- Last updated on GMT

Related tags Clinical research Europe European union

CRO Argint is to provide Brookwood clinical research training courses in Eastern Europe to meet demand created by trial growth in the region.

When it formed in 2006 Argint found Central and Southern Eastern Europe (CEE, SEE) lacked clinical research training resources. Consequently, it sent its clinical research associates to the UK to take part in training courses offered by Brookwood International Academy.

Brookwood and Argint have now expanded their relationship to bring training courses to CEE and SEE. This will expand the “very limited options​” currently available to firms seeking to train staff in the region, Steve Dobbin, chief operating officer at Argint, told Outsourcing-Pharma.

Dobbin said growth in numbers of clinical research professionals has lagged behind increases in clinical trials. This has created a need for training which can produce the skilled workforce required to support sustainable growth in the region.

Argint plans to meet this need by offering Brookwood training courses. This entails Argint trainers running courses using methods and materials provided by Brookwood. Argint will use its knowledge of CEE and SEE to help Brookwood expand its geographic reach.

Currently Argint employs one trainer but plans to expand the team in the near future. These trainers will learn the Brookwood methodology with a view to offering the first course, titled 'Foundation Course in Clinical Research’, in the first quarter of 2011.

Argint has discussed the courses with some clients that have expressed an interest. Furthermore, Brookwood has contacts with major pharma companies and will use these to support Argint. Dobbin said the partners intend to have “a very collaborative relationship​”.

Training courses will be run by Argint in Austria, Bulgaria, Bosnia-Herzegovina, Croatia, Czech Republic, Hungary, Macedonia, Moldova, Poland, Romania, Serbia, Slovakia and Slovenia.

Financial details of the deal have not been disclosed.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars